2 hours Leede Financial Reiterates “C$8.25” Price Target for Medexus Pharmaceuticals (TSE:MDP) MarketBeat
Leede Financial set a C$8.25 price objective on shares of Medexus Pharmaceuticals and gave the company a “speculative buy” rating in a research note on Monday.